Option Care Health
OPCH · NASDAQ
About OPCH
- Employees
- 6,528
- Headquarters
- Bannockburn, Illinois
- Listed
- Aug 15, 1996
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- optioncarehealth.com
OPCH key statistics
- Market cap
- 4.70B
- Price-earnings ratio
- 23.64
- Dividend yield
- —
- Average volume
- 7.16M
- Volume
- 2.74M
- Open price
- $31.27
- High today
- $31.38
- Low today
- $31.20
- 52 Week high
- $36.80
- 52 Week low
- $18.01
Option Care Health (OPCH) at a glance
As of Oct 20, 2026, Option Care Health (OPCH) shares are priced at $31.36, giving the company a market cap of 4.70B and a price-to-earnings ratio of 23.64.
Today the stock has traded between $31.20 and $31.38. The current price is 0.5% above the day's low and 0.1% below its high.
Volume so far is 2.74M shares, below the average of 7.16M shares a day.
Over the past year Option Care Health has ranged from $18.01 to $36.80, and now sits 71% of the way up that range.
Option Care Health met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.45 per share against an estimate of $0.4362.
The average analyst price target is $28.75, 8.3% below the current price, from 12 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy16.7%
- Hold83.3%
- Sell0.0%
- Low
- $23.23
- Now
- $31.36
- High
- $40.95
OPCH earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 3.4% on average.
- Q3 FY24: reported $0.31 per share against an estimate of $0.3128
- Q4 FY24: reported $0.35 per share against an estimate of $0.3427
- Q1 FY25: reported $0.28 per share against an estimate of $0.3086
- Q2 FY25: reported $0.41 per share against an estimate of $0.3949
- Q3 FY25: reported $0.45 per share against an estimate of $0.4386
- Q4 FY25: reported $0.46 per share against an estimate of $0.4673
- Q1 FY26: reported $0.40 per share against an estimate of $0.3793
- Q2 FY26: reported $0.45 per share against an estimate of $0.4362
OPCH news
- Press releasePRNewswire
- Press releasePRNewswire
Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with SBS Law
- Press releasePRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Option Care Health, Inc. (NASDAQ: OPCH)
- Caroline Ryan
Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy
- Press releaseBusiness Wire
Option Care Health Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Option Care Health, Inc. - OPCH
- Press releasePRNewswire
OPCH SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES OPTION CARE HEALTH, INC.
Similar companies
Companies in the same industry as Option Care Health
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.